Advances and Challenges in Antiviral Development for Respiratory Viruses

Advances and Challenges in Antiviral Development for Respiratory Viruses

The development of antivirals for respiratory viruses has advanced markedly in response to the growing threat of pathogens such as Influenzavirus (IAV), respiratory syncytial virus (RSV), and SARS-CoV-2. This article reviews the advances and challenges in this field, highlighting therapeutic strateg...

Full description

Saved in:
Bibliographic Details
Main Authors: Luis Adrián De Jesús-González, Moisés León-Juárez, Flor Itzel Lira-Hernández, Bruno Rivas-Santiago, Manuel Adrián Velázquez-Cervantes, Iridiana Monserrat Méndez-Delgado, Daniela Itzel Macías-Guerrero, Jonathan Hernández-Castillo, Ximena Hernández-Rodríguez, Daniela Nahomi Calderón-Sandate, Willy Salvador Mata-Martínez, José Manuel Reyes-Ruíz, Juan Fidel Osuna-Ramos, Ana Cristina García-Herrera
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Pathogens
Subjects:
antivirals
respiratory viruses
viral replication
entry inhibition
drug repurposing
Online Access:https://www.mdpi.com/2076-0817/14/1/20
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2076-0817/14/1/20

Similar Items